Cosmo Artificial Intelligence – AI

Dublin, Ireland  All Ireland companies → Founded 1997
Clinical AI Platform Healthcare Conglomerate Medical Device / Hardware
Colorectal Surgery Gastroenterology Oncology
Gastroenterology AI
Publicly Traded — N/A (Publicly Traded; significant strategic partnerships, e.g., $100M upfront from Medtronic)

Products

GI Genius™ Module 300
Cosmo Artificial Intelligence - AI
Gastroenterology AI
The GI Genius™ Module 300 is an FDA-cleared, AI-powered computer-aided detection system that assists physicians in real-time polyp and lesion detection during colonoscopies, enhancing adenoma detection rates and improving early diagnosis of colorectal cancer.
ColonPRO™ 4.0 (CPRO40S-US)
Cosmo Artificial Intelligence - AI
Gastroenterology AI
ColonPRO™ 4.0 is an FDA-cleared, AI-powered computer-assisted detection system that integrates with standard colonoscopy equipment to help endoscopists identify colonic polyps and adenomas in real-time, improving detection rates during screening and surveillance procedures.
GI Genius
Cosmo Artificial Intelligence - AI
Gastroenterology AI
GI Genius is the first FDA-cleared AI-powered endoscopy module that assists physicians in real-time polyp detection during colonoscopies to improve colorectal cancer screening and surveillance.

See all 5 products →

About Cosmo Artificial Intelligence – AI

Cosmo Pharmaceuticals N.V. is a life sciences company deeply invested in MedTech AI, alongside its established pharmaceutical work in dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). For physicians, Cosmo is pioneering the integration of artificial intelligence into medical procedures to significantly enhance detection capabilities, support clinical decision-making, and optimize workflow efficiencies. A prime example of their innovation is the GI Genius™ intelligent endoscopy module, recognized as the world’s first AI-powered polyp detection system in gastroenterology. This platform has demonstrated tangible value in routine clinical practice by assisting in the real-time detection of colorectal lesions during colonoscopy, thereby aiming to improve diagnostic accuracy and patient outcomes.

The company is strategically expanding its AI applications beyond its successful endoscopy solutions, with a clear commitment to embed AI across its entire product portfolio. This expansion includes leveraging AI in drug development for conditions such as Bile Acid Diarrhea (BAD) to advance precision medicine and predictive analytics in gastrointestinal disorders. Furthermore, Cosmo is applying AI to optimize clinical trial design, enhance patient selection, and develop personalized treatment pathways within its dermatology pipeline. Collaborating with technology leaders like NVIDIA, Cosmo’s engineering teams are focused on developing real-time AI systems for clinical environments and exploring next-generation human-machine interfaces, including the integration of GI Genius™ with spatial computing devices for live colonoscopy procedures. This forward-looking strategy underscores Cosmo’s dedication to fundamentally reshaping medicine through advanced, medical-grade AI solutions that directly support physicians and improve patient care.

Focus Areas

Gastrointestinal disorders endoscopy colorectal cancer screening polyp detection Barrett's esophagus real-time AI assistance during medical procedures MedTech AI dermatology specialty pharmaceuticals contract development and manufacturing (CDMO)

Business Intelligence

Key InvestorsCapital Group's SMALLCAP World Fund, Mauro Ajani (Founder), Dievini Hopp BioTech, Invision
PartnershipsMedtronic (global distribution of GI Genius, AI Access platform, NVIDIA collaboration), NVIDIA (Holoscan, IGX Orin technologies), Amsterdam UMC, Eindhoven University of Technology (Barrett's esophagus R&D)
AcquisitionsCassiopea (acquired by Cosmo Pharmaceuticals N.V.)
TechnologyGI Genius™ platform, AI Access™ platform, NVIDIA Holoscan, NVIDIA IGX Orin, real-time edge AI computing, software-defined medical device technology
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

Gastrointestinal AI Solutions
Cosmo Artificial Intelligence specializes in advanced AI solutions for gastrointestinal disorders, particularly in endoscopy. Their flagship product, GI Geniusu2122, is an FDA-approved AI-powered system designed to assist endoscopists in real-time detection of colonic mucosal lesions, such as polyps and adenomas, during colonoscopies. They are actively expanding this platform to include the detection of early neoplasia in Barrett's esophagus, aiming to extend AI-assisted endoscopy beyond colorectal applications.
Real-time AI Assistance
A core specialization is providing real-time AI assistance during medical procedures. The GI Geniusu2122 system analyzes live video images from standard white-light endoscopy, highlighting suspicious areas with visual markers to aid detection and support clinical decision-making without replacing physician judgment. This real-time capability is a key differentiator, assisting physicians with detection, decision support, and workflow optimization.
MedTech AI Leadership
Cosmo is recognized as a life sciences company with a strong focus on MedTech AI, committed to building medical-grade AI systems that operate effectively in real clinical environments. Their participation in leading AI conferences like NVIDIA GTC highlights their engineering excellence in developing robust, regulated medical software.
Dermatology & Specialty Pharmaceuticals
Beyond their MedTech AI focus, Cosmo Pharmaceuticals N.V. also maintains specializations in dermatology and the development and commercialization of specialty pharmaceuticals, particularly for gastrointestinal disorders.
Contract Development and Manufacturing (CDMO)
Cosmo provides contract development and manufacturing (CDMO) services, leveraging their expertise to design, develop, and manufacture advanced solutions that address critical medical needs for leading global pharmaceutical and MedTech companies.
Physician Tip

For physicians, Cosmo Artificial Intelligence offers tangible benefits through its real-time AI platforms like GI Geniusu2122. This technology can significantly improve the detection rates of challenging lesions, such as polyps in colonoscopies and early neoplasia in Barrett's esophagus, directly enhancing diagnostic accuracy and potentially improving patient outcomes. The AI acts as an intelligent assistant, providing immediate visual cues and decision support during procedures, thereby optimizing workflow and allowing physicians to focus on critical clinical judgments. The company's commitment to 'medical grade AI systems' and FDA approval for GI Geniusu2122 ensures reliability and seamless integration into existing endoscopy setups, fostering confidence in its clinical utility.

Cosmo's GI Geniusu2122 system is designed for seamless integration with standard white-light endoscopy video systems, allowing for easy adoption into existing clinical workflows without requiring significant changes to current equipment.

Products by Cosmo Artificial Intelligence – AI

5 products in the directory

GI Genius™ Module 300
Cosmo Artificial Intelligence - AI
Gastroenterology AI
The GI Genius™ Module 300 is an FDA-cleared, AI-powered computer-aided detection system that assists physicians in real-time polyp and lesion detection during colonoscopies, enhancing adenoma detection rates and improving early diagnosis of colorectal cancer.
ColonPRO™ 4.0 (CPRO40S-US)
Cosmo Artificial Intelligence - AI
Gastroenterology AI
ColonPRO™ 4.0 is an FDA-cleared, AI-powered computer-assisted detection system that integrates with standard colonoscopy equipment to help endoscopists identify colonic polyps and adenomas in real-time, improving detection rates during screening and surveillance procedures.
GI Genius
Cosmo Artificial Intelligence - AI
Gastroenterology AI
GI Genius is the first FDA-cleared AI-powered endoscopy module that assists physicians in real-time polyp detection during colonoscopies to improve colorectal cancer screening and surveillance.
GI Genius™ Module 200
Cosmo Artificial Intelligence - AI Ltd.
Gastroenterology AI
The GI Genius™ intelligent endoscopy module is the first AI-powered, computer-aided polyp detection system designed to assist endoscopists in real-time detection of colonic mucosal lesions during colonoscopies, enhancing visualization and increasing adenoma detection rates.
GI Genius™ Module 100
Cosmo Artificial Intelligence - AI
Gastroenterology AI
The GI Genius™ Module 100 is an FDA-cleared, AI-powered computer-aided detection system that assists physicians in real-time detection of colonic polyps and adenomas during colonoscopy, enhancing visualization and improving detection rates.

What the Web Says

Cosmo AI generally receives positive feedback, particularly for its ease of use in transforming text into engaging videos and its responsive customer support. It's often highlighted for its ability to automate tasks like generating quick replies and creating marketing content, which saves time and resources for small businesses. However, some users have noted limitations in customization and occasional buggy features.

Overall: Positive

Strengths

  • Easy to set up and use, especially for video creation from text.
  • Responsive and helpful customer support.
  • Efficiently automates tasks like sending quick replies and generating marketing videos.
  • Cost-effective solution for professional-grade videos without extensive editing experience.
  • Provides detailed reports on revenue, orders, and messages.
  • Seamless integration with popular platforms like Facebook, WhatsApp, and Instagram.

Limitations

  • Limited customization options for visuals and interactions.
  • Mobile version shows fewer features.
  • Some reported buggy features, leading to mismatches in visuals.
  • Doesn't forward tickets to agents unless specifically requested by clients.
  • May require manual adjustments for visuals due to missing features.
  • Background music in generated videos can be overwhelming and drown out voiceovers.

Based on reviews from: G2, Capterra, Reddit, YouTube, Medium, Insidr.ai, Trustpilot

Last updated: 2026-07-17

Videos

News, demos, and interviews about Cosmo Artificial Intelligence – AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Cosmo Artificial Intelligence – AI →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Cosmo Artificial Intelligence - AI's flagship product is the GI Geniusu2122 intelligent endoscopy module, which is an FDA-approved AI-powered device designed to assist physicians in real-time detection of lesions during colonoscopies. This system significantly improves the accuracy of colonoscopy and reduces the number of undetected precancerous polyps.
The GI Geniusu2122 module enhances colorectal cancer screening by providing real-time AI assistance during colonoscopies, which has been shown to reduce the adenoma and polyp miss rates by nearly 50% compared to standard colonoscopy. This improved detection, especially of smaller polyps, is crucial for preventing colorectal cancer.
Yes, Cosmo Artificial Intelligence - AI is actively expanding its GI Geniusu2122 platform beyond colorectal applications. The company recently announced a strategic R&D collaboration to develop an AI-based system for the identification of early neoplasia in Barrett's esophagus during upper GI endoscopy.
Cosmo Pharmaceuticals N.V., the parent company of Cosmo Artificial Intelligence - AI, is a life sciences company with a focus on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). They develop and manufacture advanced solutions, including specialty pharmaceuticals, and leverage AI to raise the standard of care in these areas.
Cosmo Artificial Intelligence - AI has significant partnerships, notably with Medtronic for the exclusive global distribution of the GI Geniusu2122 intelligent endoscopy module. They also collaborate with NVIDIA to accelerate the development of AI in healthcare, leveraging NVIDIA's advanced computing technologies for real-time AI in medical procedures.
Cosmo Artificial Intelligence - AI ensures compliance by developing its systems in accordance with applicable global quality, safety, and cybersecurity standards. The GI Geniusu2122 module, for instance, received FDA approval through the De Novo application, marking it as the first AI device for lesion detection in colonoscopies to achieve this.
Physicians can expect real-time AI assistance that operates during medical procedures, offering detection, decision support, and workflow optimization. For example, the GI Geniusu2122 module highlights suspicious areas on the screen during a colonoscopy, assisting the endoscopist in identifying lesions without looking away from the procedure.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.